Nelson, A., Clifton-Bligh, R., Mirams, M., Gill, A., Au, A., Clarkson, A., Jueppner, H., Ruff, S., Stalley, P., Scolyer, R., Robinson, B., Mason, R., et al (2003). Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia. Journal of Clinical Endocrinology and Metabolism, 88(9), 4088-4094. [More Information]